Evidence map›Paper›PMID 42099991›Full record

ArticleMaterials today. Bio2026

Uniform pore morphology of bijel-templated materials reduces cell circularity and inflammatory expression of macrophages.

Alyse R Gonthier, Elliot L Botvinick, Ali Mohraz

Abstract read
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alyse R GonthierDepartment of Materials Science and Engineering, University of California, Irvine, CA, 92697, USA.
Elliot L BotvinickDepartment of Biomedical Engineering, University of California, Irvine, CA, 92697, USA.
Ali MohrazDepartment of Materials Science and Engineering, University of California, Irvine, CA, 92697, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design of implantable biomaterials often aims to guide local cell behavior to control immune response. Non-chemical routes exploit the effect of mechanical properties and structure morphology on cell behavior. A class of substrates known as bicontinuous interfacially jammed emulsion gel (bijel)-templated materials (BTMs) exhibit characteristically uniform pore size and surface curvature. Existing research on these materials in vivo demonstrates their ability to modulate the inflammatory response in the anti-inflammatory direction. We investigate a subset of the contributing components to that effect by examining the behavior and phenotype of macrophages within BTMs in vitro. The comparative substrate, the particle-templated material (PTM), has an equivalent chemical composition, but has variable pore size and surface curvature. Macrophages within these two materials take on notably different cell shapes and phenotypes. Macrophages interacting with the BTM exhibit less circular cell shapes and a lower state of inflammation. This effect is significant enough to induce lower pro-fibrotic activation in fibroblasts, without direct BTM-fibroblast contact. These results suggest that microscale curvature and pore size have a direct effect on macrophages, and that this effect can cause phenotypic changes in other cells. Findings reaffirm the significance of targeting macrophages in biomaterials design and support further investigation of the immune signaling cascade that occurs within BTMs. Our contributions to the fundamental knowledge of cell behaviors in these porous materials provide new insights applicable to advancing biomaterials design.

Indexed as

BijelCell shapeInflammationMacrophagePorous material

Identifiers

PMID42099991
PMCPMC13147999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.